cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Charles River Laboratories International
6 own
6 watching
Current Price
$250.35
$-9.57
(-3.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
12,737.06M
52-Week High
52-Week High
349.84
52-Week Low
52-Week Low
181.36
Average Volume
Average Volume
0.41M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
48.7805
iconMarket Capitalization12,737.06M
icon52-Week High349.84
icon52-Week Low181.36
iconAverage Volume0.41M
iconDividend Yield--
iconP/E Ratio48.7805
What does the Charles River Laboratories International do?
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening preclinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs and chickens used in the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Read More
How much money does Charles River Laboratories International make?
News & Events about Charles River Laboratories International.
Business Wire
6days ago
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired SAMDI Tech, Inc, a leading provider of high-quality, label-free high-throughput screening (HTS) solutions for drug discovery research. The acquisition marks the culmination of a partnership between the...
Globe Newswire
10days ago
LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) -- iVexSol Inc., a technology-based lentiviral vector (LVV) contract development and manufacturing organization (CDMO), announced $23.8 million in Series A-3 funding. New investors Bristol Myers Squibb (NYSE: BMY), Charles River Laboratories (NYSE: ...
Business Wire
18days ago
Charles River Laboratories International, Inc. (NYSE: CRL) and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, today announced a viral vector contract development and manufacturing organization (CDMO) partnership. Rznomics...
Business Wire
20days ago
Charles River Laboratories International, Inc. (NYSE:CRL) today announced the launch of their new CliniPrimeTM suite of Good Manufacturing Practice (GMP)-compliant cellular starting materials. CliniPrime products provide rapid access to starting materials for cell, and gene-modified cell therapies...
Benzinga
24days ago
Over the past three months, shares of Charles River Inc. (NYSE:CRL) increased by 16.70%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials. read more...
Frequently Asked Questions
Frequently Asked Questions
What is Charles River Laboratories International share price today?
plus_minus_icon
Can Indians buy Charles River Laboratories International shares?
plus_minus_icon
How can I buy Charles River Laboratories International shares from India?
plus_minus_icon
Can Fractional shares of Charles River Laboratories International be purchased?
plus_minus_icon
What are the documents required to start investing in Charles River Laboratories International stocks?
plus_minus_icon
What is today’s traded volume of Charles River Laboratories International?
plus_minus_icon
What is today’s market capitalisation of Charles River Laboratories International?
plus_minus_icon
What is the 52-Week High and Low Range of Charles River Laboratories International?
plus_minus_icon
What percentage is Charles River Laboratories International down from its 52-Week High?
plus_minus_icon
What percentage is Charles River Laboratories International up from its 52-Week Low?
plus_minus_icon
Current Price
$250.35
$-9.57
(-3.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00